Geron Corporation (GERN) 6.55 -0.17

Trade GERN
NOW!
Last Trade:5.90Short Ratio:13.50
Last Trade Time:4:00pmDay Range:5.85 - 6.10
Ask:6.55Year Range:4.03 - 9.24
Bid:5.88One Year Target:7.63
Open:6.06Exchange:NGM
Volume:1159669EBITDA:-68.5M
Prev. Close:6.07Market Cap:575.0M
50 Day Moving:5.8178Div Yield:
200 day moving:6.1058PE:

Benzinga’s Top Pre-Market Gainers (STP, URBN, PETM, GERN, SIGM)

Posted on 03/04/10 at 9:25am
Suntech Power Holdings Co., Ltd. (ADR) (NYSE: STP) increased 4.90% to $14.35 in the pre-market session. Suntech reported a fourth-quarter profit of $49.9 million, or $0.27 per share, as compared to a loss of $109.1 million, or $0.69 per share for the same quarter last year. Analysts had expected STP to report earnings of $0.12 per share.
Click here to read the rest of the article
Posted in

Geron Highlights Product Launch from Collaboration with Corning – the Synthemax™ Surface for Scalable Growth of Human Embryonic Stem Cells

Posted on 03/03/10 at 5:36pm
MENLO PARK, Calif.--(BUSINESS WIRE)-- Geron Corporation (Nasdaq: GERN) today announced that Corning Incorporated (NYSE: GLW) has launched the Synthemax™ surface, a new synthetic matrix for growing human embryonic stem cells (hESCs), developed u
Click here to read the rest of the article

Corning Incorporated Introduces New Synthemax™ Synthetic Surface to Enhance and Support Stem Cell Growth

Posted on 03/03/10 at 5:36pm
CORNING, N.Y.--(BUSINESS WIRE)-- Corning Incorporated (NYSE: GLW) today introduced the Corning® Synthemax™ surface, a novel synthetic surface that supports the growth and differentiation of stem cells.
Click here to read the rest of the article

Presentations on Geron’s Telomerase Inhibitor At AACR Special Conference

Posted on 03/02/10 at 8:36am
MENLO PARK, Calif.--(BUSINESS WIRE)-- Geron Corporation (Nasdaq: GERN) today announced several presentations at the American Association for Cancer Research (AACR) Special Conference on The Role of Telomeres and Telomerase in Cancer Research held in Fort Worth, TX between February 27
Click here to read the rest of the article

Geron Corporation Reports Fourth Quarter and Annual 2009 Financial Results and Highlights

Posted on 02/25/10 at 5:31pm
MENLO PARK, Calif.--(BUSINESS WIRE)-- Geron Corporation (Nasdaq: GERN) today reported financial results for the fourth quarter and year ended December 31, 2009. Fourth Quarter 2009 and Year End Results
Click here to read the rest of the article

Geron Announces Conference Call to Discuss Fourth Quarter and Annual 2009 Financial Results and Highlights

Posted on 02/23/10 at 7:03pm
MENLO PARK, Calif.--(BUSINESS WIRE)-- Geron Corporation (Nasdaq: GERN) will announce its financial results for the 2009 fourth quarter and year end on Thursday, February 25, 2010, after the closing of the equity market. Thomas B.
Click here to read the rest of the article

Geron to Present at the BIO CEO & Investor Conference

Posted on 02/08/10 at 8:33am
MENLO PARK, Calif.--(BUSINESS WIRE)-- Geron Corporation (Nasdaq: GERN) today announced that Thomas B. Okarma, Ph.D., M.D., president and chief executive officer, will present an update of the company’s product development programs at 10:30 a.m.
Click here to read the rest of the article